Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$150,000.00
Sep 1, 2016
Transcriptional regulation of the antibiotic resistance and persistence gene ndvB in Pseudomonas aeruginosa biofilms
$108,000.00
Sep 1, 2016
Making SPARX Fly in Nunavut: Testing A Computer-based Cognitive Behaviour Therapy Intervention for Inuit Youth Experiencing Depression
$150,000.00
Sep 1, 2016
Identification of Novel Therapies for High Risk Metastatic Neuroblastoma
$105,000.00
Sep 1, 2016
The Effect of Cognitive Restructuring Placement on Expectancy Violation in Exposure Therapy for Agoraphobia.
$105,000.00
Sep 1, 2016
Identification and Targeting Oncogenic and Metastatic Driver Genes in Pineoblastoma Induced by Tumour Suppressor Rb/p53- Deficiency
$150,000.00
Sep 1, 2016
"Kill-switch" enabled, immune-silent, non-cytopathic, and persistent paramyxovirus vector for respiratory gene therapy.
$135,000.00
Sep 1, 2016
Motivational Mechanisms Leading to Changes in Suicidality in a Randomized Controlled Trial of Dialectical Behaviour Therapy (DBT) for Suicidal Patients
$150,000.00
Sep 1, 2016
Sleep apnea in epilepsy: Assessing the cognitive burden of and the effects of continuous positive airway pressure therapy on cognition and epilepsy severity
$105,000.00
Sep 1, 2016
Increasing cognitive performance, neuronal plasticity and survival using non-invasive delivery of neurotrophic genes
$150,000.00
Sep 1, 2016
Control of human cell survival proliferation and lineage identity by synthetic gene circuits